| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Tullman Stephen A. is a Director at Aclaris Therapeutics, Inc.. Recent SEC Form 4 filings include 4 buys and 0 sells.
Estimated insider holdings value: $862K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 4, 2018 | ACRS Aclaris Therapeutics, Inc. | Director | Buy | 7,100 | $14.00 | $99,370.18 | +4.2% | |
| Aug 23, 2018 | ACRS Aclaris Therapeutics, Inc. | Director | Buy | 6,600 | $15.00 | $98,984.82 | +4.0% | |
| Aug 15, 2018 | ACRS Aclaris Therapeutics, Inc. | Director | Buy | 6,250 | $15.97 | $99,812.50 | +4.0% | |
| Apr 6, 2018 | ACRS Aclaris Therapeutics, Inc. | Director | Buy | 26,700 | $16.54 | $441,618.00 | +20.4% |